INCIDENCE AND RISK FACTORS FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH DIRECT-ACTING ANTIVIRALS (DAAS).

被引：0
|
作者：
Leal, Cassia [1 ,2 ]
Teixeira, Rosangela [3 ]
Perez, Renata M. [4 ]
Theodoro, Carmem Ferguson [2 ]
Guarana, Thais [2 ]
Strogoff De Mattos, Jorge Paulo [5 ]
Noronha, Tatiana Guimaraes [6 ]
Aparecida Pinto, Paulo De Tarso [1 ]
Oliveira, Solange Artimos [5 ]
机构：
[1] Hosp Fed Servidores Estado Rio De Janeiro, Gastroenterol & Hepatol, Rio De Janeiro, Brazil
[2] Univ Fed Fluminense, Gastroenterol & Hepatol Unit, Rio De Janeiro, Brazil
[3] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil
[4] Univ Hosp Clementino Fraga Filho Ufrj, Hepatol, Rio De Janeiro, Brazil
[5] Fluminense Fed Univ, Clin Med Dept, Rio De Janeiro, Brazil
[6] Fluminense Fed Univ, Dept Materno Infantil, Rio De Janeiro, Brazil
来源：
HEPATOLOGY | 2023年 / 77卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
5037
引用
收藏
页码：E149 / E150
页数：2
相关论文
共 50 条
  • [1] Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C Treated with Direct-Acting Antivirals
    Leal, Cassia
    Strogoff-de-Matos, Jorge
    Theodoro, Carmem
    Teixeira, Rosangela
    Perez, Renata
    Guarana, Thais
    Pinto, Paulo de Tarso
    Guimaraes, Tatiana
    Artimos, Solange
    VIRUSES-BASEL, 2023, 15 (01):
  • [2] Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan
    Chi, Chen-Ta
    Chen, Chi-Yi
    Su, Chien-Wei
    Chen, Po-Yueh
    Chu, Chi-Jen
    Lan, Keng-Hsin
    Lee, I-Cheng
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2021, 54 (03) : 385 - 395
  • [3] Risk Factors Contributing to the Occurrence and Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Patients Treated with Direct-Acting Antivirals
    Kishta, Sara
    Tabll, Ashraf
    Kolaric, Tea Omanovic
    Smolic, Robert
    Smolic, Martina
    BIOMEDICINES, 2020, 8 (06) : 1 - 15
  • [4] The Direct-Acting Antivirals for Hepatitis C Virus and the Risk for Hepatocellular Carcinoma
    Chinchilla-Lopez, Paulina
    Qi, Xingshun
    Yoshida, Eric M.
    Mendez-Sanchez, Nahum
    ANNALS OF HEPATOLOGY, 2017, 16 (03) : 328 - 330
  • [5] Impact of direct-acting antivirals (DAAs) on cardiovascular diseases in patients with chronic hepatitis C
    Pennisi, Grazia
    Spatola, Federica
    Di Marco, Lorenza
    Di Martino, Vincenzo
    Di Marco, Vito
    MINERVA GASTROENTEROLOGY, 2021, 67 (03): : 254 - 263
  • [6] Incidence of depression in patients with hepatitis C treated with direct-acting antivirals
    Egmond, Elfi
    Marino, Zoe
    Navines, Ricard
    Oriolo, Giovanni
    Pla, Anna
    Bartres, Concepcio
    Lens, Sabela
    Forns, Xavier
    Martin-Santos, Rocio
    BRAZILIAN JOURNAL OF PSYCHIATRY, 2020, 42 (01) : 72 - 76
  • [7] Impact of direct-acting antivirals on the recurrence of hepatocellular carcinoma in chronic hepatitis C
    Tagkou, Nikoletta M.
    Goossens, Nicolas
    Negro, Francesco
    HEPATOMA RESEARCH, 2022, 8
  • [8] No difference between direct-acting antivirals for hepatitis C in hepatocellular carcinoma risk
    Mun, Elijah J.
    Green, Pamela
    Berry, Kristin
    Ioannou, George N.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (01) : 47 - 52
  • [9] No Difference between Direct-Acting Antivirals for Hepatitis C in Hepatocellular Carcinoma Risk
    Mun, Elijah
    Green, Pamela
    Berry, Kristin
    Ioannou, George
    HEPATOLOGY, 2018, 68 : 389A - 389A
  • [10] Risk of hepatocellular carcinoma and efficacy of direct-acting antivirals in patients with concurrent hepatitis C virus
    Harrod, Elizabeth
    Agarwal, Ritu
    Tabrizian, Parissa
    Rayapudi, Madhavi
    Ala, Aftab
    Fiel, Isabel
    Schwartz, Myron
    Dieterich, Douglas
    Friedman, Scott
    Saberi, Behnam
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E733 - E734
12345